160 related articles for article (PubMed ID: 32096253)
41. Slightly elevated blood pressure as well as poor metabolic control are risk factors for the progression of retinopathy in early-onset Japanese Type 2 diabetes.
Okudaira M; Yokoyama H; Otani T; Uchigata Y; Iwamoto Y
J Diabetes Complications; 2000; 14(5):281-7. PubMed ID: 11113692
[TBL] [Abstract][Full Text] [Related]
42. Prevalence and determinants of retinopathy in a cohort of Lebanese type II diabetic patients.
Salti HI; Nasrallah MP; Taleb NM; Merheb M; Haddad S; El-Annan J; Khouri A; Salti IS
Can J Ophthalmol; 2009 Jun; 44(3):308-13. PubMed ID: 19491987
[TBL] [Abstract][Full Text] [Related]
43. A classification model for predicting eye disease in newly diagnosed people with type 2 diabetes.
Cichosz SL; Johansen MD; Knudsen ST; Hansen TK; Hejlesen O
Diabetes Res Clin Pract; 2015 May; 108(2):210-5. PubMed ID: 25765665
[TBL] [Abstract][Full Text] [Related]
44. Dynamic Responses in Retinal Vessel Caliber With Flicker Light Stimulation and Risk of Diabetic Retinopathy and Its Progression.
Lim LS; Ling LH; Ong PG; Foulds W; Tai ES; Wong TY
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2449-2455. PubMed ID: 28460046
[TBL] [Abstract][Full Text] [Related]
45. Prevalence and risk factors for diabetic retinopathy in Asian Indians with young onset type 1 and type 2 diabetes.
Rajalakshmi R; Amutha A; Ranjani H; Ali MK; Unnikrishnan R; Anjana RM; Narayan KM; Mohan V
J Diabetes Complications; 2014; 28(3):291-7. PubMed ID: 24512748
[TBL] [Abstract][Full Text] [Related]
46. Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.
Klein R; Myers CE; Lee KE; Paterson AD; Cruickshanks KJ; Tsai MY; Gangnon RE; Klein BE
JAMA Ophthalmol; 2015 Sep; 133(9):1054-61. PubMed ID: 26181138
[TBL] [Abstract][Full Text] [Related]
47. People With Type 1 Diabetes of African Caribbean Ethnicity Are at Increased Risk of Developing Sight-Threatening Diabetic Retinopathy.
Mangelis A; Wijewickrama P; Nirmalakumaran A; Fountoulakis N; Vas P; Webster L; Mann S; Collins J; Hopkins D; Thomas S; Ayis S; Karalliedde J
Diabetes Care; 2023 May; 46(5):1091-1097. PubMed ID: 37062044
[TBL] [Abstract][Full Text] [Related]
48. Retinopathy develops at similar glucose levels but higher HbA
Staimez LR; Rhee MK; Deng Y; Safo SE; Butler SM; Legvold BT; Jackson SL; Ford CN; Wilson PWF; Long Q; Phillips LS
Diabet Med; 2020 Jun; 37(6):1049-1057. PubMed ID: 32125000
[TBL] [Abstract][Full Text] [Related]
49. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, Report 33).
Raman R; Gupta A; Kulothungan V; Sharma T
Curr Eye Res; 2012 Jun; 37(6):513-23. PubMed ID: 22577770
[TBL] [Abstract][Full Text] [Related]
50. Retinopathy predicts progression of fasting plasma glucose: An Early Diabetes Intervention Program (EDIP) analysis.
Patel YR; Kirkman MS; Considine RV; Hannon TS; Mather KJ
J Diabetes Complications; 2017 Mar; 31(3):605-610. PubMed ID: 28003103
[TBL] [Abstract][Full Text] [Related]
51. Association Between Obesity and Microvascular Diseases in Patients With Type 2 Diabetes Mellitus.
Gao S; Zhang H; Long C; Xing Z
Front Endocrinol (Lausanne); 2021; 12():719515. PubMed ID: 34764938
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for progression of diabetic retinopathy in Alberta First Nations communities.
Rudnisky CJ; Wong BK; Virani H; Tennant MT
Can J Ophthalmol; 2012 Aug; 47(4):365-75. PubMed ID: 22883847
[TBL] [Abstract][Full Text] [Related]
53. The use of statistical methodology to determine the accuracy of grading within a diabetic retinopathy screening programme.
Oke JL; Stratton IM; Aldington SJ; Stevens RJ; Scanlon PH
Diabet Med; 2016 Jul; 33(7):896-903. PubMed ID: 26666463
[TBL] [Abstract][Full Text] [Related]
54. Blood pressure is a risk factor for progression of diabetic retinopathy in normotensive patients with type 2 diabetes: correlation with carotid intima-media thickness.
Saif A; Karawya S; Abdelhamid A
Endocr Regul; 2014 Oct; 48(4):189-94. PubMed ID: 25512192
[TBL] [Abstract][Full Text] [Related]
55. Diabetic retinopathy assessed by fundus photography in Pima Indians with impaired glucose tolerance and NIDDM.
Nagi DK; Pettitt DJ; Bennett PH; Klein R; Knowler WC
Diabet Med; 1997 Jun; 14(6):449-56. PubMed ID: 9212309
[TBL] [Abstract][Full Text] [Related]
56. Body mass index: a risk factor for retinopathy in type 2 diabetic patients.
Kaštelan S; Tomić M; Gverović Antunica A; Ljubić S; Salopek Rabatić J; Karabatić M
Mediators Inflamm; 2013; 2013():436329. PubMed ID: 24347825
[TBL] [Abstract][Full Text] [Related]
57. The prognosis of diabetic retinopathy in patients with type 2 diabetes since 1996-1998: the Skaraborg Diabetes Register.
Garberg G; Lövestam-Adrian M; Nasic S; Boström KB
Int Ophthalmol; 2015 Aug; 35(4):503-11. PubMed ID: 25143261
[TBL] [Abstract][Full Text] [Related]
58. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial.
Diabetes; 1995 Aug; 44(8):968-83. PubMed ID: 7622004
[TBL] [Abstract][Full Text] [Related]
59. Association between visit-to-visit variability of glycated albumin and diabetic retinopathy among patients with type 2 diabetes - A prospective cohort study.
Dai D; Shen Y; Lu J; Wang Y; Zhu W; Bao Y; Hu G; Zhou J
J Diabetes Complications; 2021 Sep; 35(9):107971. PubMed ID: 34187717
[TBL] [Abstract][Full Text] [Related]
60. Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study.
Rosenstock J; Fonseca V; McGill JB; Riddle M; Hallé JP; Hramiak I; Johnston P; Davis M
Diabetologia; 2009 Sep; 52(9):1778-88. PubMed ID: 19526210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
